Suspension of trading

Company Acorda Therapeutics OTC Markets

Stocks

ACOR

US00484M7002

Biotechnology & Medical Research

Market Closed - OTC Markets Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		-10.00%	-99.91%

24-08-13	First Motion for Exclusivity Period Extension Approved For Acorda Therapeutics, Inc.	CI
24-08-07	Modified First Amended Joint Liquidation Plan Approved for Acorda Therapeutics, Inc.	CI

Business description: Acorda Therapeutics

Acorda Therapeutics, Inc. is a biopharmaceutical company focused on developing therapies that restore function and improve the lives of people with neurological disorders. The Company markets Inbrija (levodopa inhalation powder), which is approved in the United States for intermittent treatment of OFF episodes, also known as OFF periods, in people with Parkinsonâ€™s disease treated with carbidopa/levodopa. Inbrija is not to be used by patients who take or have taken a nonselective monoamine oxidase inhibitor, such as phenelzine or tranylcypromine within the last two weeks. Inbrija utilizes its ARCUS pulmonary delivery system, a technology platform designed to deliver medication through inhalation. ARCUS is a dry-powder pulmonary drug delivery technology. It also markets the branded AMPYRA (dalfampridine) extended-release tablets, 10 mg, to improve walking in adults with multiple sclerosis. Ampyra is marketed as Fampyra outside the United States by Biogen International GmbH.

Sales by Activity: Acorda Therapeutics

Fiscal Period: December	2019 (USD)	2020 (USD)	2021 (USD)	2022 (USD)	2023 (USD)
Developing Therapies	192M	153M	129M	119M	118M

See all business segments

Geographical breakdown of sales: Acorda Therapeutics

Fiscal Period: December	2019 (USD)	2020 (USD)	2021 (USD)	2022 (USD)	2023 (USD)
United States	192M	153M	129M	119M	118M

See all geographic segments

Executive Committee: Acorda Therapeutics

Manager	Title	Age	Since
Sofia Ali COO	Chief Operating Officer	-	-

See ACORDA THERAPEUTICS governance

Company details: Acorda Therapeutics

Acorda Therapeutics, Inc.

28 Liberty Street

10005, New York

+(914) 347-4300

http://www.acorda.com

Bio Therapeutic Drugs

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ARGENX SE	+0.68%	+5.92%	+80.45%	+137.78%	59.1B
WUXI APPTEC CO., LTD.	+2.32%	+5.03%	+75.51%	+94.88%	55.19B
BIONTECH SE	+3.86%	+6.93%	-11.32%	-9.53%	24.67B
INSMED INCORPORATED	+4.30%	+7.95%	+14.11%	+437.83%	24.19B
WUXI BIOLOGICS (CAYMAN) INC.	+4.74%	+13.68%	+45.58%	-1.42%	19.69B
GENMAB A/S	-0.29%	+9.78%	+44.62%	-27.94%	17.56B
PHARMAESSENTIA CORPORATION	0.00%	+20.78%	+178.93%	+360.74%	16.22B
EXELIXIS, INC.	+3.50%	+1.97%	+21.02%	+191.95%	14.04B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	+6.72%	+19.38%	+42.82%	-	14.84B
Average	+2.87%	+8.57%	+54.64%	+148.04%	27.28B
Weighted average by Cap.	+2.46%	+6.47%	+59.06%	+137.71%